Tuesday Morning With Justin: Healthcare, Leadership & Life
Send us Fan Mail [https://www.buzzsprout.com/1949549/fan_mail/new] Gene therapy can cure diseases that once felt untouchable, but it can also trigger the biggest claim a self-funded employer may ever face. We focus on the hidden costs around the drug, why network contracting matters, and how transparency and preparation protect the health plan when rare cases hit. • Gene therapy risk for self-funded employers beyond the drug price • Hidden cost drivers like hospital stays, administration, and follow-up care • Contract loopholes and vague network terms that inflate total allowed cost • Why specialized gene therapy networks can run cheaper on average • The real-world math on how often gene therapy and transplant cases occur • Preparing for financial earthquakes with better planning and transparency The urgency that gene therapy is already here, not years away. Let me know if you want to discuss how to get more control of your outstanding risk. Music by Alex Lambert. Support the show [https://www.buzzsprout.com/1949549/support] Contact Justin via text 740-525-5259 or via email JFutrell@TrueNorthCompanies.com I welcome the opportunity to hear your feedback from this episode! Thanks again to my musically gifted friend Alex Lambert for the music. Also thanks to Kevin Asehan for the edits.
20 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Tuesday Morning With Justin: Healthcare, Leadership & Life!